FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefuroxime Axetil (Ceftin) Oral Suspension
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

GlaxoSmithKline (New 07/24/2017)

Company Contact Information:
888-825-5249

Presentation Posting Date Related Information
125 mg/5 mL; 100-mL bottles (NDC 0173-0740-00) 07/24/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy. The anticipated final date of availability of 125 mg/5 mL 100-mL bottles to patients is April 1, 2018 (NDC 0173-0740-00).
250mg/5mL; 50-mL bottles (NDC 0173-0741-10) 07/24/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy. The anticipated final date of availability of 250mg/5mL 50-mL bottles to patients is January 15, 2018 (NDC 0173-0741-10).
250mg/5mL; 100-mL bottles (NDC 0173-0741-00) 07/24/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy. The anticipated final date of availability of 250mg/5mL 100-mL bottles to patients is February 15, 2018 (NDC 0173-0741-00).

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English